Data / Drug companies / Target Corporation
Target Corporation: 331 products in the FDA NDC directory, labeler code 11673
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Target Corporation (labeler code 11673) lists 331 products in the FDA National Drug Code Directory, covering 144 finished drugs by generic name. By type: 331 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 7, 2026.
The request: Watch Target Corporation (FDA labeler code 11673): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 11673
- Products in commercial distribution
- 331
- Packages
- 464
- Finished drugs by generic name
- 144
- Prescription products
- 0
- Over the counter products
- 331
- Flagged as original packager
- 309 of 309 products that carry the flag
- Started marketing in the last 12 months
- 8
- Products with a marketing end date set
- 14
- Earliest marketing start
- July 15, 1989
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 244 | 73.7% |
| Generic drugs (ANDA) | 72 | 21.8% |
| New drug applications (NDA) | 13 | 3.9% |
| Other unapproved drugs | 1 | 0.3% |
| Unapproved homeopathic products | 1 | 0.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 331 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 37 | 11.2% |
| Tablet | 32 | 9.7% |
| Gel | 31 | 9.4% |
| Liquid | 25 | 7.6% |
| Kit | 24 | 7.3% |
| Capsule, liquid filled | 21 | 6.3% |
| Cream | 18 | 5.4% |
| Lotion | 12 | 3.6% |
| Tablet, coated | 12 | 3.6% |
| Suspension | 12 | 3.6% |
| Tablet, film coated | 11 | 3.3% |
| Solution | 11 | 3.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dextromethorphan polistirex | 11673-033 | Suspension, extended release | Generic drugs (ANDA) | October 7, 2026 |
| Diclofenac Sodium | 11673-028 | Gel | Generic drugs (ANDA) | September 1, 2026 |
| Simethicone | 11673-549 | Tablet, chewable | Over the counter monograph drugs | July 1, 2026 |
| Daytime Nighttime | 11673-591 | Kit | Over the counter monograph drugs | June 1, 2026 |
| Daytime Nighttime | 11673-474 | Kit | Over the counter monograph drugs | June 1, 2026 |
| Benzalkonium chloride | 11673-681 | Aerosol, foam | Over the counter monograph drugs | December 11, 2025 |
| Cetirizine HCl | 11673-650 | Capsule | New drug applications (NDA) | December 9, 2025 |
| Naproxen Sodium | 11673-651 | Capsule, liquid filled | New drug applications (NDA) | December 8, 2025 |
| Motion Sickness Relief | 11673-356 | Tablet | Over the counter monograph drugs | November 5, 2025 |
| Up and Up Dry Eye Relief Lubricant Eye Drops | 11673-771 | Solution/ drops | Over the counter monograph drugs | October 31, 2025 |
| Target Kids Watermelon Mint | 11673-308 | Paste, dentifrice | Over the counter monograph drugs | October 17, 2025 |
| Non-Drowsy Allergy Relief | 11673-621 | Tablet | Generic drugs (ANDA) | August 1, 2025 |
| Acetaminophen gelcaps | 11673-674 | Tablet | Over the counter monograph drugs | July 10, 2025 |
| Gas Relief - Cherry Flavor | 11673-066 | Tablet, chewable | Over the counter monograph drugs | June 29, 2025 |
| Extra Strength Antacid Smooth Dissolving - Assorted Fruit | 11673-659 | Tablet, chewable | Over the counter monograph drugs | June 27, 2025 |
| Extra Strength Antacid Smooth dissolving - Berry Fusion Flavors | 11673-568 | Tablet, chewable | Over the counter monograph drugs | June 27, 2025 |
| Stool Softener Laxative | 11673-512 | Capsule, liquid filled | Over the counter monograph drugs | June 25, 2025 |
| 5-Symptom Digestive Relief | 11673-291 | Suspension | Over the counter monograph drugs | June 16, 2025 |
| Multi-Symptom Menstrual Relief | 11673-363 | Tablet | Over the counter monograph drugs | April 7, 2025 |
| Daytime Nighttime Sinus Relief | 11673-530 | Kit | Over the counter monograph drugs | April 6, 2025 |
| Day cold and flu | 11673-347 | Tablet, coated | Over the counter monograph drugs | April 1, 2025 |
| Motion Sickness Relief | 11673-354 | Tablet | Over the counter monograph drugs | March 31, 2025 |
| Jock Itch Cream | 11673-436 | Cream | Generic drugs (ANDA) | November 15, 2024 |
| Kids Strawberry FTP | 11673-441 | Paste, dentifrice | Over the counter monograph drugs | October 14, 2024 |
| Guaifenesin | 11673-840 | Tablet | Generic drugs (ANDA) | August 1, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.